Yves Allory

15.1k citations
228 papers · 7.1k · 1 hit paper · h-index 48

Impact in

Papers in

    • Prostate Cancer Diagnosis and Treatment 56
    • Prostate Cancer Treatment and Research 26
    • Renal cell carcinoma treatment 19
    • Bladder and Urothelial Cancer Treatments 78
    • Urinary and Genital Oncology Studies 25

Yves Allory

213 papers receiving 7.0k citations

Yves Allory's Hit Papers

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses 2020 · 157 citations
1570+2+4Years since publication50100150

Peers

Yves Allory
Comparison fields: 5 of 134
  • Pulmonary and Respiratory Medicine 2.7k
  • Cancer Research 1.0k
  • Urology 315
  • Molecular Biology 2.5k
  • Oncology 872
Replace Nicolas Wernert with:
Nicolas Wernert Germany
Christopher S. Foster United Kingdom
Donna E. Hansel United States
Timothy C. Thompson United States
Nam Hoon Cho South Korea
David Waltregny Belgium
Neil A. Bhowmick United States
A Hittmair Austria
Masatoshi Eto Japan
Bhaskar Kallakury United States
Yves Allory relative to Nicolas Wernert Germany Nicolas Wernert's profile →
Citations per field
00.5×
Nicolas Wernert · 1×
Citations per year

Countries citing papers authored by Yves Allory

Since Specialization
Citations

This map shows the geographic impact of Yves Allory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Allory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Allory more than expected).

Fields of papers citing papers by Yves Allory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Allory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Allory. The network helps show where Yves Allory may publish in the future.

Co-authors

The 25 scholars most cited alongside Yves Allory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yves Allory Line = papers co-authored together Yves Allory links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 228 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1999289
2 2010240
3 2019237
4 2010233
5 2009231
6 2006177
7
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses
Hit paper breakdown →
2020157
8 2007154
9 2014135
10 2007131
11 2010122
12 2014121
13 2006117
14 2010111
15 2021109
16 200597
17 201796
18 201296
19 200896
20 201486

About Yves Allory

Yves Allory is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Cancer Research, having authored 228 papers that have together received 7.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (78 papers), Prostate Cancer Diagnosis and Treatment (56 papers), Prostate Cancer Treatment and Research (26 papers), Urinary and Genital Oncology Studies (25 papers), Renal cell carcinoma treatment (19 papers), Epigenetics and DNA Methylation (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Renal and related cancers (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.7k citations), Cancer Research (1.0k citations), Urology (315 citations), Molecular Biology (2.5k citations) and Oncology (872 citations). Yves Allory has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Alexandre de la Taille, Laurent Salomon, Dimitri Vordos, Francis Vacherot, François Radvanyi, András Hoznek, Stéphane Terry, Guillaume Ploussard, Nathalie Nicolaı̈ew and Jean‐Claude Courvalin. Their work appears in journals such as British Journal of Urology, The Journal of Urology, European Urology, World Journal of Urology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact